FIELD: chemistry of peptides. SUBSTANCE: product: peptide derivatives of the general formula (I): R1-A-CH2-(R2)-CON(R7)-CH2(R3)-CON(R6)-CO(R4)R5 where: R1 - hydrogen or acyl; R2 - lower alkyl, aryl-(lower)-alkyl; (C3-C7)-cycloalkyl-(lower)-alkyl; heterocyclic-(lower)-alkyl where heterocyclic group is the unsaturated 5,6-membered heteromonocyclic group containing 1-2 nitrogen atoms optionally substituted with imino-protective group; R3 - heterocyclic-(lower)-alkyl being heterocyclic group can be unsaturated fused 9-membered one containing one nitrogen atom and optionally substituted with a suitable substituent taken from (lower)-alkyl and imino-protective group, aryl-(lower)-alkyl; R4 - H, aryl-(lower)-alkyl, (lower)-alkyl, amino-(lower)-alkyl (free or protective one) and free or protective heterocyclic-(lower)-alkyl; heterocyclic group can be the unsaturated 5-6-membered one containing 1 or 2 nitrogen atoms or one sulfur atom and one nitrogen atom and optionally substituted imino-protective group; R5 - carboxy, protected carboxy, carboxy-(lower)-alkyl (free or protected one); R6 - H, heterocyclic-(lower)-alkyl where heterocyclic group is the saturated 6-membered heterocycle with one nitrogen atom; R7 - H or (lower)-alkyl; A - -O-, NH, (lower)-alkylimino, lower alkylene, or their pharmaceutically acceptable salts. Method of synthesis of compounds of the formula (I) involves condensation of two fragments R1ACH2(R2)-COOH and R7NHCH(R3)CON(R6)CH(R4)R8, and pharmaceutical composition containing pharmaceutically acceptable carrier and peptide derivative of the formula (I) as an active component taken at effective dose. The synthesized compounds were used in medicine for hypertension treatment and prophylaxis. EFFECT: improved method of synthesis. 8 cl
Title |
Year |
Author |
Number |
DERIVATIVES OF TRIFLUOROMETHYLKETONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1991 |
- Kejdzi Khemmi[Jp]
- Itiro Sima[Jp]
- Kejsuke Imai[Jp]
- Khirokazu Tanaka[Jp]
|
RU2073684C1 |
DERIVATIVES OF PYRAZOLO-[1,5-A]-PYRIDINE OR THEIR PHARMACEUTICAL ACCEPTABLE SALTS AND METHOD OF THEIR SYNTHESIS |
1992 |
- Euiti Siokava[Jp]
- Atsusi Akakhane[Jp]
- Khirokhito Katajama[Jp]
- Takafumi Mitsunaga[Jp]
|
RU2069662C1 |
OCTANE OXASPIRO [2,5]DERIVATIVE AND PROCESS FOR PREPARATION THEREOF (VARIANTS) |
1989 |
- Teruo Oku[Jp]
- Tiesi Kasakhara[Jp]
- Takekhiko Okhkava[Jp]
- Masasi Khasimoto[Jp]
|
RU2068412C1 |
AMINO ACID DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1991 |
- Kejdzi Khemmi[Jp]
- Masakhiro Neja[Jp]
- Khirosi Marusava[Jp]
- Kejzuke Imai[Jp]
- Natsuko Kajakiri[Jp]
- Masasi Khasimoto[Jp]
|
RU2070195C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DISEASE TREATMENT INTERMEDIARY AGENT OF THAT IS TACHIKININ |
1991 |
- Masaaki Matsuo[Jp]
- Dajdziro Khagivara[Jp]
- Khirosi Mijake[Jp]
|
RU2073683C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1992 |
- Tokhru Kino[Jp]
- Motoaki Nisikava[Jp]
- Masami Izaki[Jp]
- Sumio Kijoto[Jp]
|
RU2043365C1 |
AMINO ACID DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALT AND A METHOD OF THEIR SYNTHESIS |
1991 |
- Kejdzi Khemmi[Jp]
- Masakhiro Neja[Jp]
- Khirosi Marusava[Jp]
- Sin'Ja Vatanabe[Jp]
- Masasi Khasimoto[Jp]
|
RU2057124C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND ELIMINATION OF THROMBOSIS |
1992 |
- Khisasi Takasuki[Jp]
- Akito Tanaka[Jp]
- Khiroesi Sakai[Jp]
- Takatosi Isikava[Jp]
|
RU2103276C1 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Norikhiko Simazaki
- Sinja Vatanabe
- Akikhiko Savada
- Kejdzi Khemmi
|
RU2170737C2 |
INDOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND A METHOD OF THEIR SYNTHESIS |
1991 |
- Satosi Okada[Jp]
- Kozo Savada[Jp]
- Natsuko Kajakiri[Jp]
- Juki Saitokh[Jp]
- Khirokazu Tanaka[Jp]
- Masasi Khasimoto[Jp]
|
RU2045518C1 |